Eminence Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-487,147
Closed -$171M 37
2025
Q4
$171M Buy
487,147
+120,358
+33% +$40.7M 2.7% 17
2025
Q3
$119M Buy
366,789
+125,632
+52% +$39.1M 1.44% 31
2025
Q2
$93.8M Sell
241,157
-317,514
-57% -$128M 1.13% 37
2025
Q1
$243M Buy
558,671
+3,126
+0.6% +$1.25M 4.06% 4
2024
Q4
$205M Buy
555,545
+324,511
+140% +$136M 3.14% 4
2024
Q3
$120M Sell
231,034
-25,098
-10% -$13.4M 1.69% 27
2024
Q2
$139M Buy
256,132
+17,408
+7% +$9.2M 2.24% 21
2024
Q1
$124M Buy
238,724
+72,823
+44% +$36.2M 1.75% 23
2023
Q4
$78.2M Buy
165,901
+89
+0.1% +$41.2K 1.18% 37
2023
Q3
$72.2M Buy
165,812
+3,416
+2% +$1.55M 1.43% 37
2023
Q2
$72.2M Buy
162,396
+40,323
+33% +$18.6M 0.95% 42
2023
Q1
$56.1M Buy
+122,073
New +$58.1M 0.8% 47
2021
Q3
Sell
-140,916
Closed -$53.8M 71
2021
Q2
$53.8M Sell
140,916
-193,826
-58% -$74.1M 0.66% 49
2021
Q1
$120M Sell
334,742
-77,822
-19% -$25M 1.49% 30
2020
Q4
$132M Sell
412,564
-41,236
-9% -$12.7M 1.24% 30
2020
Q3
$122M Buy
453,800
+315,024
+227% +$84.8M 1.19% 28
2020
Q2
$36.5M Buy
+138,776
New +$37M 0.36% 60
2018
Q1
Sell
-447,815
Closed -$101M 41
2017
Q4
$101M Sell
447,815
-298,416
-40% -$63.6M 1.54% 29
2017
Q3
$142M Sell
746,231
-12,632
-2% -$2.4M 2.29% 18
2017
Q2
$143M Sell
758,863
-234,231
-24% -$42.1M 2.43% 21
2017
Q1
$164M Buy
993,094
+20,985
+2% +$3.34M 2.94% 10
2016
Q4
$140M Sell
972,109
-13,554
-1% -$1.81M 2.19% 17
2016
Q3
$124M Buy
985,663
+331,460
+51% +$42.8M 2.06% 20
2016
Q2
$85.9M Buy
654,203
+302,326
+86% +$41.4M 1.74% 26
2016
Q1
$48.9M Buy
+351,877
New +$47M 0.86% 35

Other funds holding ELV